Latest Blogs, Articles, and More View More >>
Many Young Patients With Cancer Unaware of Fertility Preservation Options
BY ANDREW J. ROTH
It is known that the fertility of adolescent and young adult patients with cancer can be put at risk by treatments, but little research has been conducted looking at awareness, counseling and actions in this area.
Tiptoes and Cancerversaries
BY DANA STEWART
Deciding how to approach a cancer anniversary can be exciting, scary or maybe just somewhere in between.
Crossing the Divide
BY DEBU TRIPATHY
Understanding how the immune system controls itself has led to advances in immunotherapy.
Great Possibilities
BY MIKE HENNESSY
Patient success stories illustrate the hope promised by cancer immunotherapy.
Seeing Red
BY MICHAEL A. POSTOW
Rash is the most common side effect of cancer immunotherapies, but patients should watch for more serious issues.
Avastin After Recurrence in Glioblastoma Shows No Benefit
BY BRIDGET M. KUEHN
Continuing Avastin (bevacizumab) in patients with recurrent glioblastoma after progression of the disease does not improve patient outcomes, according to results from the phase 2 CABARET trial.
IDH Mutation Status May Guide Therapy in Patients With High-Risk Low-Grade Glioma
BY STAFF WRITER
An analysis of three interrelated biomarkers in high-risk low-grade glioma (LGG) has identified distinct risk groups by isocitrate dehydrogenase (IDH) mutation status and suggested appropriate treatment strategies.
View More >>
Special Feature
ShareYourStory
$auto_registration$